Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Sahar K, Hegazy"'
Publikováno v:
Journal of Clinical Virology Plus, Vol 3, Iss 2, Pp 100151- (2023)
Background: Corona Virus disease - 2019 (COVID-19) disease induces scientific research to find a control to this pandemic from 2020 year up to now. Recently, various advances in pharmacotherapy against COVID-19 have emerged. Objectives: To compare th
Externí odkaz:
https://doaj.org/article/2d895c70db904b16a303ff57207a452c
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 145, Iss , Pp 112399- (2022)
Background: Irritable bowel syndrome (IBS) is a functional gastrointestinal condition marked by chronic bowel pain or discomfort, as well as changes in abdominal motility. Despite its worldwide prevalence and clinical impact, the cause of IBS is unkn
Externí odkaz:
https://doaj.org/article/4ee74657a09b4c18aa2c8a8fc9d5b97d
IntroductionCorona Virus-induced disease – 2019 (COVID-19) pandemic stimulates research works to find a solution to this crisis from starting 2020 year up to now. With ending of the 2021 year, various advances in pharmacotherapy against COVID-19 ha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ffe2e79b3eac95d7bd88456d910ae223
https://doi.org/10.21203/rs.3.rs-1991618/v2
https://doi.org/10.21203/rs.3.rs-1991618/v2
Autor:
Sahar M El-Haggar, Sahar K Hegazy, Sherief M Abd-Elsalam, Eslam B Elkaeed, Ahmed A Al-Karmalawy, Mostafa M Bahaa
Publikováno v:
Journal of Inflammation Research. 15:1159-1172
Sahar M El-Haggar,1 Sahar K Hegazy,1 Sherief M Abd-Elsalam,2 Eslam B Elkaeed,3 Ahmed A Al-Karmalawy,4 Mostafa M Bahaa5 1Clinical Pharmacy Department, Faculty of Pharmacy, Tanta University, El-Gharbia Government, Tanta, 31527, Egypt; 2Tropical Medicin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d873563d81a2beac0d6e9cea933151ef
https://doi.org/10.2147/jir.s346608
https://doi.org/10.2147/jir.s346608
Introduction: Corona Virus induced disease – 2019 (COVID-19) disaster motivates scientific research to find a settling to this pandemic. With ending of 2021 year, various advances in immunotherapy against COVID-19 have emerged. Regarding antiviral
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::610a9104ace91301ad86328f4a4ba8c4
https://doi.org/10.21203/rs.3.rs-1991618/v1
https://doi.org/10.21203/rs.3.rs-1991618/v1
Publikováno v:
European Journal of Clinical Pharmacology. 77:1825-1834
Investigating the efficacy and safety of rupatadine (RUP) versus montelukast (MON) as adjuvant therapy for patients with rheumatoid arthritis (RA). From December 2018 to December 2019, 75 patients with active RA were enrolled in this randomized doubl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::742fdd51928e4294a646059392e63f8a
https://doi.org/10.1007/s00228-021-03181-2
https://doi.org/10.1007/s00228-021-03181-2
Publikováno v:
Asian Journal of Pharmaceutical and Clinical Research. :172-179
Objective: Endothelial dysfunction is afflicted to the maturation of arteriosclerosis and type 2 diabetes mellitus (T2DM) vascular complications. This study designed to evaluate the impact of fenofibrate adjuvant therapy on endothelial dysfunction an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fbad341ba02cec38cc4d2e48b274a7b7
https://doi.org/10.22159/ajpcr.2020.v13i3.36733
https://doi.org/10.22159/ajpcr.2020.v13i3.36733
Publikováno v:
Journal of clinical pharmacy and therapeuticsREFERENCES.. 47(3)
What is known and objectives There is clear evidence for an association between irritable bowel syndrome (IBS) and visceral hypersensitivity. This clinical study aimed to assess the adjunct role of ethosuximide, an antiepileptic drug with T-type calc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13d39e92a3cb7b48dd4ccbaf5e6f651b
https://pubmed.ncbi.nlm.nih.gov/34726293
https://pubmed.ncbi.nlm.nih.gov/34726293
Publikováno v:
Life Sciences. 299:120536
Metastatic colorectal cancer (mCRC) predominantly contributes to cancer-related mortalities secondary to distant metastasis. This study aimed at investigating anti-tumor activity and safety of mebendazole in patients with mCRC.This prospective, rando
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12cdb10dca9fcb80f896381da75c912e
https://doi.org/10.1016/j.lfs.2022.120536
https://doi.org/10.1016/j.lfs.2022.120536
Publikováno v:
Medical Oncology. 38
The development of drug resistance remains the major obstacle to clinical efficacy of cancer chemotherapy. Consequently, finding new therapeutic options for cancerous patients is an urgent need. Sixty newly diagnosed diffuse large B-cell lymphoma (DL
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::64daa1ccb1d3a11ee3d5705d3dafa483
https://doi.org/10.1007/s12032-020-01452-z
https://doi.org/10.1007/s12032-020-01452-z